Analytical Services Center for Medications Development Program

这项研究和开发合同将提供生物分析化学资源，以支持NIDA的药物开发计划。本合同还将提供一个集中的生物分析机构，对各种化合物进行定量和/或定性分析，包括但不限于新药和/或其代谢物、滥用药物/代谢物、潜在的伴随药物/化合物和分子生物标志物（小分子、肽和蛋白质）。

This research and development contract will provide bioanalytical chemistry resources to support NIDA's medications development program. This contract will also provide as a centralized bioanalytical facility to carry out quantitative and/or qualitative assays for a variety of compounds, including but not limited to, new medications and/or their metabolites, abused drugs/metabolites, potential concomitant medications/compounds and molecular biomarkers(small molecules, peptides and proteins).